GVAG
Great Valley Advisor Group Portfolio holdings
AUM
$4.51B
1-Year Return
15.05%
This Quarter Return
+6.92%
1 Year Return
+15.05%
3 Year Return
+61.62%
5 Year Return
+96.05%
10 Year Return
–
AUM
$2.14B
AUM Growth
+$188M
(+9.6%)
Cap. Flow
+$79.9M
Cap. Flow
% of AUM
3.72%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
758
New
67
Increased
298
Reduced
278
Closed
60
Top Buys
Top Sells
| 1 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
$17.5M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$11.5M |
| 3 |
PGIM Ultra Short Bond ETF
PULS
|
$7.68M |
| 4 |
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
$6.73M |
| 5 |
NVIDIA
NVDA
|
$6.61M |
Sector Composition
| 1 | Technology | 10.47% |
| 2 | Healthcare | 4.29% |
| 3 | Consumer Discretionary | 3.5% |
| 4 | Financials | 3.46% |
| 5 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Clorox
CLX
$15.5B
| $897K | 0.04% |
5,670
+2
| +0% | +$316 |
|
327
Philip Morris
PM
$251B
| $895K | 0.04% |
9,201
-25
| -0.3% | -$2.43K |
|
328
Xcel Energy
XEL
$43B
| $883K | 0.04% |
13,103
+16
| +0.1% | +$1.08K |
|
329
Deckers Outdoor
DECK
$17.9B
| $873K | 0.04% |
11,658
-26,766
| -70% | -$2M |
|
330
Chubb
CB
$111B
| $873K | 0.04% |
+4,496
| New | +$873K |
|
331
Enbridge
ENB
$105B
| $866K | 0.04% |
22,700
-5,780
| -20% | -$221K |
|
332
ASML
ASML
$307B
| $864K | 0.04% |
1,269
-193
| -13% | -$131K |
|
333
Goldman Sachs
GS
$223B
| $850K | 0.04% |
2,598
-1,208
| -32% | -$395K |
|
334
Avantis US Equity ETF
AVUS
$9.49B
| $818K | 0.04% |
11,548
+3,189
| +38% | +$226K |
|
335
Utilities Select Sector SPDR Fund
XLU
$20.7B
| $818K | 0.04% |
12,084
-27,445
| -69% | -$1.86M |
|
336
iShares S&P Small-Cap 600 Growth ETF
IJT
$6.28B
| $815K | 0.04% |
7,413
-896
| -11% | -$98.5K |
|
337
Monster Beverage
MNST
$61B
| $815K | 0.04% |
15,088
+1,540
| +11% | +$83.1K |
|
338
Mastercard
MA
$528B
| $814K | 0.04% |
2,241
-194
| -8% | -$70.5K |
|
339
Entergy
ETR
$39.2B
| $799K | 0.04% |
14,830
| – | – |
|
340
Gilead Sciences
GILD
$143B
| $799K | 0.04% |
9,627
+2,633
| +38% | +$218K |
|
341
Sonoco
SON
$4.56B
| $794K | 0.04% |
+13,019
| New | +$794K |
|
342
Marvell Technology
MRVL
$54.6B
| $791K | 0.04% |
18,260
-4,103
| -18% | -$178K |
|
343
Duke Energy
DUK
$93.8B
| $787K | 0.04% |
8,166
+598
| +8% | +$57.7K |
|
344
Oneok
OKE
$45.7B
| $786K | 0.04% |
12,378
-4,084
| -25% | -$259K |
|
345
SPDR S&P 600 Small Cap Growth ETF
SLYG
$3.56B
| $785K | 0.04% |
10,651
-60
| -0.6% | -$4.42K |
|
346
iShares US Medical Devices ETF
IHI
$4.35B
| $782K | 0.04% |
14,484
-2,142
| -13% | -$116K |
|
347
Vanguard Extended Market ETF
VXF
$24.1B
| $781K | 0.04% |
5,570
-312
| -5% | -$43.7K |
|
348
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.15B
| $780K | 0.04% |
11,736
+219
| +2% | +$14.6K |
|
349
Invesco S&P 500 Revenue ETF
RWL
$6.28B
| $769K | 0.04% |
10,116
+286
| +3% | +$21.8K |
|
350
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $767K | 0.04% |
10,062
-1,373
| -12% | -$105K |
|